Since then, nbix stock has increased by 9.7% and is now trading at $94.25. This chart shows the closing price for nbix for the last year in relation to the current analyst high, average, and low pricetarget.
PFC (Power Finance Corporation Limited) BUY ABOVE 98.5
These metrics, and several others, help hkmpf earn a value grade of b, while nbix has been given a value grade of d.
Nbix stock forecast zacks. Cvx stock price from 03/31/2021 to 06/30/2021: By comparison, nbix has a p/b of 18.48. Get the latest neurocrine biosciences, inc.
Continue to slide 2 ». Top 10 stocks held by zacks investment management by holdings channel staff, updated wednesday, september 15, 5:59 am. Texas mineral resources stock forecast, tmrc stock price prediction.
The zacks consensus estimate for the current year has improved 0.9% over the last 30 days. Neurocrine biosciences (nasdaq:nbix) was upgraded by zacks investment research from a sell rating to a hold rating in a report issued on wednesday, zacks.com reports. Find the latest earnings report date for neurocrine biosciences, inc.
The p/b is a method of comparing a stock's market value to its book value, which is defined as total assets minus total liabilities. Continue to slide 2 ». The average price target is $119.31, with a high forecast of $163.00 and a low forecast of $90.00.
Common stock (nbix) at nasdaq.com. Nbix description — neurocrine biosciences, inc. This compares to loss of $1.12 per share a year ago.
Zacks earnings numbers are reported on a bnri. The percent of ownership held by large financial institutions or organizations. Investors use the p/b ratio to look at a stock's market value versus its book value, which is defined as total assets minus total liabilities.
By comparison, nbix has a p/b of 17.15. The average price target represents a 27.86% upside from the last price of $93.31. Nbix investment & stock information.
Is primarily focused on the commercialization of ingrezza® (valbenazine) in the united states. Coefficient that measures the volatility of a stock's returns relative to the market (s&p 500). Neurocrine biosciences (nbix) is seeing favorable earnings estimate revision activity and has a positive zacks earnings esp heading into earnings season.
Neurocrine biosciences (nbix) came out with quarterly earnings of $0.82 per share, beating the zacks consensus estimate of $0.56 per share. Get the latest price and consensus chart for neurocrine biosciences, inc. Which stock is the better value option?
Professional wrestler John Cena punches above his weight
Pin von Zack Viola auf firearms Star wars charaktere
Periódico Metro (Reino Unido). Periódicos de Reino Unido
Tags: forecast, nbix, stock, zacks